ANDA 89647, held by Pharmaceutical Associates. Codeine Phosphate; Promethazine Hydrochloride.
As of Nov 21, 2026, ANDA 89647 (Promethazine Hydrochloride and Codeine Phosphate), held by Pharmaceutical Associates, was first approved by FDA on Dec 22, 1988, with 12 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 22, 1988 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine Hydrochloride and Codeine Phosphate10MG/5ML;6.25MG/5ML · syrup;oral | Codeine Phosphate; Promethazine Hydrochloride | Discontinued |
| Dec 15, 2023 | Supplement 17Labeling · Standard review | Approved | None posted |
| Jun 28, 2018 | Supplement 16Labeling · Standard review | Approved | None posted |
| Jun 19, 2018 | Supplement 15Labeling · Standard review | Approved | None posted |
| Jun 19, 2018 | Supplement 14Labeling · Standard review | Approved | None posted |
| Aug 29, 2017 | Supplement 13Labeling · Standard review | Approved | None posted |
| Aug 29, 2017 | Supplement 12Labeling · Standard review | Approved | None posted |
| Jan 13, 2017 | Supplement 11Labeling · Standard review | Approved | None posted |
| May 10, 2013 | Supplement 10Labeling · Standard review | Approved | None posted |
| Jan 21, 2010 | Supplement 7Labeling | Approved | None posted |
| Jan 23, 2009 | Supplement 6Labeling | Approved | None posted |
| Dec 19, 2008 | Supplement 5Labeling | Approved | None posted |
| Dec 17, 2004 | Supplement 3Labeling | Approved | None posted |
| Dec 22, 1988 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters